Document ID: chunk:federal_register_of_legislation:F2025C00081:clause:2_34
Version: federal_register_of_legislation:F2025C00081
Segment Type: clause
Provision Reference: sch 2 cl 34
Character Range: 86047–87006

34
  The pharmaceutical reimbursement is a financial amount that would compensate an Eligible Person for out‑of‑pocket expenses:
 (a) that the person incurred in respect of a Pharmaceutical benefit provided under this Scheme; or
 (b) that the person incurred in respect of a Pharmaceutical benefit provided other than under this Scheme but provided on or from a date when the Commission accepted liability to provide treatment to the person under the Act.
Note 1: under the Acts Interpretation Act 1901 words in the singular number (e.g. Pharmaceutical benefit) include the plural and words in the plural number include the singular.
Note 2: paragraph (b) covers what are known as "MEPIs" (Medical Expenses Privately Incurred).  Under the Act eligibility for treatment can be backdated for 3 months before a claim for pension is received and treatment costs incurred in that period e.g. co‑payments for Pharmaceutical benefits, may be met by the Department.